Am. J. Respir. Crit. Care Med., Vol 154, No. 4, Oct 1996, 858-865.
Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse
H Scheerens, TL Buckley, EM Davidse, J Garssen, FP Nijkamp and H Van Loveren
Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands.
Toluene diisocyantate (TDI) is a low-molecular-weight compound that is
known to cause occupational asthma in 5% to 10% of exposed workers. These
patients exhibit marked airway hyperresponsiveness and granulocyte
accumulation in the airways, and 10% to 20% were also determined to have
TDI-specific IgE in their serum. In this study, we developed a murine model
for TDI-induced asthma. After several sensitization and challenge regimens
were tested, it was decided that optimal sensitization was observed after
mice (BALB/c) were skin sensitized with TDI (1%) two times on two
consecutive days and challenged intranasally 8 d later with TDI (1%).
Sensitized mice exhibited tracheal hyperreactivity to carbachol 24 h after
challenge (69% increase in maximal contractile response). In contrast, no
differences between the control and TDI-treated groups was observed 2 and
48 h after challenge with 1% TDI. There appeared to be no elevation in
TDI-specific IgE antibodies in the serum at all time points measured. In
addition, no influx of leukocytes could be detected histologically in the
trachea and lung tissue or airway lumen 2, 24, and 48 h after the
challenge. Surprisingly, the tracheal hyperreactivity was associated with a
marked increase in myeloperoxidase but not eosinophil peroxidase activity
in the lung tissue and in the cells of the bronchoalveolar lavage fluid at
24 h after the challenge. To investigate the role of lymphocytes in the
induction of tracheal hyperreactivity, mice were passively sensitized by
intravenous injection of lymphoid cells from TDI-sensitized donor mice.
Similar to active sensitization, adoptive transfer of lymphocytes from
sensitized donors resulted in tracheal hyperreactivity 24 h after challenge
of the recipients. In conclusion, these data show that TDI is capable of
inducing lymphocyte-dependent but IgE-independent tracheal hyperreactivity
in the mouse that is not associated with cellular infiltration in the
airways. This model can be used to further investigate the possible
mechanisms involved in the development of occupational asthma induced by
TDl.
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Matheson, V. J. Johnson, and M. I. Luster
Immune Mediators in a Murine Model for Occupational Asthma: Studies with Toluene Diisocyanate
Toxicol. Sci.,
March 1, 2005;
84(1):
99 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. J. Vanoirbeek, M. Tarkowski, J. L. Ceuppens, E. K. Verbeken, B. Nemery, and P. H. M. Hoet
Respiratory Response to Toluene Diisocyanate Depends on Prior Frequency and Concentration of Dermal Sensitization in Mice
Toxicol. Sci.,
August 1, 2004;
80(2):
310 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. J. Vanoirbeek, C. Mandervelt, A. R. Cunningham, P. H. M. Hoet, H. Xu, H. M. Vanhooren, and B. Nemery
Validity of Methods to Predict the Respiratory Sensitizing Potential of Chemicals: A Study with a Piperidinyl Chlorotriazine Derivative That Caused an Outbreak of Occupational Asthma
Toxicol. Sci.,
December 1, 2003;
76(2):
338 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sastre, O. Vandenplas, and H-S. Park
Pathogenesis of occupational asthma
Eur. Respir. J.,
August 1, 2003;
22(2):
364 - 373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Redlich, A. V. Wisnewski, and T. Gordon
Mouse Models of Diisocyanate Asthma
Am. J. Respir. Cell Mol. Biol.,
October 1, 2002;
27(4):
385 - 390.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Matheson, R. Lemus, R. W. Lange, M. H. Karol, and M. I. Luster
Role of Tumor Necrosis Factor in Toluene Diisocyanate Asthma
Am. J. Respir. Cell Mol. Biol.,
October 1, 2002;
27(4):
396 - 405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Kraneveld, H. P. M. van der Kleij, M. Kool, A. H. van Houwelingen, A. C. D. Weitenberg, F. A. M. Redegeld, and F. P. Nijkamp
Key Role for Mast Cells in Nonatopic Asthma
J. Immunol.,
August 15, 2002;
169(4):
2044 - 2053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. SCHEERENS, T. L. BUCKLEY, T. L. MUIS, J. GARSSEN, J. DORMANS, F. P. NIJKAMP, and H. VAN LOVEREN
Long-term Topical Exposure to Toluene Diisocyanate in Mice Leads to Antibody Production and In Vivo Airway Hyperresponsiveness Three Hours after Intranasal Challenge
Am. J. Respir. Crit. Care Med.,
April 1, 1999;
159(4):
1074 - 1080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. MAPP, R. E. LUCCHINI, D. MIOTTO, P. CHITANO, L. JOVINE, M. SAETTA, P. MAESTRELLI, D. R. SPRINGALL, J. POLAK, and L. M. FABBRI
Immunization and Challenge with Toluene Diisocyanate Decrease Tachykinin and Calcitonin Gene-Related Peptide Immunoreactivity in Guinea Pig Central Airways
Am. J. Respir. Crit. Care Med.,
July 1, 1998;
158(1):
263 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|